Mazdutide

GLP-1 / Glucagon

Weight loss and metabolic control

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Peptide
Primary mechanism: Dual GLP-1/glucagon receptor agonism
Primary market use: Obesity/diabetes

Pharmacology

Molecular weight (Da): ~3900
Oral bioavailability: N/A
Half-life: ~4-7 d
Route tags: SubQ; Injectable; route-dependent
Evidence level: Clinical
Clinical status: Investigational/approved status varies by region
Value-for-money score: 6 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Requires ongoing dosing

Sources

https://clinicaltrials.gov/